Axalta Coating Systems Ltd. Axalta Releases Second Quarter 2026 Results

Axalta Coating Systems Ltd. (NYSE:AXTA) reported Q2 2026 results for the quarter ended June 30. Net sales rose 3% to $1.35B. Net income was $89M (6.6% margin) and diluted EPS was $0.41. Adjusted EBITDA hit a record $305M (22.7% margin) and adjusted diluted EPS was $0.72. Axalta forecast Q3 net sales LSD and FY 2026 adjusted EBITDA $1.14B-$1.17B, adjusted EPS $2.55-$2.70, and free cash flow >$500M.

Original reporting
Published Jul 28, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 11:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AXTA
Bullish
medium confidence
Mentioned
$AXTA
Relevance
8/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$AXTABullishMed
01

Why it matters

The release combines a quantified earnings and cash-flow update with explicit Q3 and FY 2026 guidance ranges, creating a direct benchmark for traders managing earnings expectations. It also reinforces merger timing as a near-term catalyst.

02

Market read

Record Adjusted EBITDA and Adjusted Diluted EPS plus improved leverage and FCF support a constructive earnings narrative, while GAAP EPS weakness tied to M&A costs and merger execution risk can limit upside.

03

What to watch

Free cash flow is described as inclusive of merger-related headwinds, so the sustainability of cash generation post-merger execution and integration costs remains a key risk.

Relevance 8/10Novelty 7/10Timing: after-hours/market reaction to Q2 2026 results and ahead of the Aug 5 shareholder vote on the AkzoNobel merger

Background

Axalta released Q2 2026 results for the quarter ended June 30, 2026, and reiterated momentum while pointing to an Aug 5 Special General Meeting to approve its merger of equals with AkzoNobel.

Company-level read

Ticker impact

$AXTABullishMedium confidence
Context

Axalta reported Q2 2026 net sales of $1.35B, record Adjusted EBITDA of $305M, and guided FY 2026 Adjusted Diluted EPS to $2.55-$2.70.

Expected impact

Likely supportive for the stock versus prior expectations if investors focus on Adjusted EPS and FCF, but GAAP EPS weakness from M&A costs may temper enthusiasm.

Evidence & confidence

The article provides multiple quantified beats/records (Adjusted EBITDA, Adjusted Diluted EPS, FCF) plus explicit Q3 and FY guidance ranges, which are actionable for positioning.

Market effects

Coatings peers may see read-across on demand stability (Europe/Asia strength) and pricing/mix resilience, but the key driver is Axalta-specific margin and cash generation.

Management cites stronger growth in Europe and Asia versus lower North America volumes, which can influence regional sentiment for automotive/refinish coatings demand.

The proposed merger with AkzoNobel keeps consolidation optionality in focus for the global coatings market, potentially affecting competitive pricing expectations.

Counterpoint

Investors may discount the Adjusted metrics because GAAP net income and diluted EPS declined, with the decline attributed to elevated merger-related costs.

Key entities

  • Axalta Coating Systems Ltd.

    Reported Q2 2026 results, record Adjusted EBITDA and Adjusted Diluted EPS, and provided Q3 and FY 2026 outlook; also referenced the Aug 5 shareholder vote for the AkzoNobel merger.

  • AkzoNobel N.V.

    Named as the merger-of-equals partner; Axalta seeks shareholder approval for the transaction on Aug 5.

Related articles

$AXTAMed

Shareholders Approve AkzoNobel, Axalta Merger

AkzoNobel shareholders approved all resolutions at an EGM for the proposed all-share merger with Axalta Coating Systems, and Axalta shareholders also voted in favor. AkzoNobel said the deal can move to the next phase, pending regulatory approvals and other closing conditions. Completion is expected end-2026 or early-2027.

$AKZOYMedAI 8/10

AkzoNobel (AKZOF) investors approve all-share Axalta merger

AkzoNobel shareholders approved all resolutions for the proposed all-share merger with Axalta at an Aug. 5, 2026 extraordinary general meeting, including merger approval, share issuance, board appointments and remuneration policy. Axalta shareholders also voted in favor. The deal moves to regulatory review and other closing conditions, with completion expected end-2026 or early 2027.

$AXTAMed

Axalta and Akzo Nobel shareholders approve merger of equals in landmark coatings industry vote

Axalta Coating Systems and Akzo Nobel said shareholders approved their all-stock merger of equals at meetings on 5 Aug 2026. Akzo Nobel approved merger-related resolutions including share issuance, board appointments and remuneration policy, while Axalta approved the deal at its special meeting. Completion still depends on regulatory approvals and customary closing conditions, expected late 2026 or early 2027.